Company news
Cipher Pharmaceuticals Inc. news in 2021
Cipher Pharmaceuticals Inc.'s news releases, calls and decks from 2021, newest first.
Cipher Announces Third Quarter and Year-to-Date 2021 Financial Results
November 11, 2021
Cipher Pharmaceuticals Schedules Q3 2021 Earnings Release and Conference Call
November 3, 2021
Cipher Pharmaceuticals Announces Renewal of Normal Course Issuer Bid
September 8, 2021
Cipher Reports 30% Revenue Growth and 40% Adjusted EBITDA Growth in Second Quarter of 2021, Driven by Strength in Epuris and Absorica
August 12, 2021
Cipher Pharmaceuticals Schedules Q2 2021 Earnings Release and Conference Call
August 9, 2021
Cipher Pharmaceuticals Reports Voting Results From Annual Meeting of Shareholders
June 23, 2021
Cipher Pharmaceuticals Reports First Quarter 2021 Financial Results
May 13, 2021
Cipher Pharmaceuticals Schedules Q1 2021 Earnings Release and Conference Call
May 5, 2021
Cipher Pharmaceuticals Announces Automatic Repurchase Plan Pursuant to its Normal Course Issuer Bid
March 25, 2021
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
March 18, 2021
Cipher Pharmaceuticals Schedules Q4 2020 Earnings Release and Conference Call
March 10, 2021
Cipher Pharmaceuticals Enters into Co-Promotion Agreement with Verity Pharmaceuticals Inc.
February 10, 2021
Cipher Pharmaceuticals Receives Arbitration Award on Trulance®
January 15, 2021